| Financial Year |
March 31 2023 |
| Monetary Funds |
2,589,191,289.67 |
| Held-for-trading Financial Assets |
1,305,082,109.57 |
| Notes Receivable |
168,968,083.24 |
| Accounts Receivable |
143,280,350.27 |
| Advances to Suppliers |
73,607,995.39 |
| Other Receivables |
60,237,331.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,851,140,912.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,989,138.19 |
| Total Current Assets |
8,798,133,380.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
21,076,344.88 |
| Investment Properties |
34,829,600.00 |
| Fixed Assetes |
1,049,786,448.58 |
| Under-construction Projects |
601,000,357.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
303,536,255.39 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
37,712,621.03 |
| Deferred Income Tax Assets |
79,003,242.99 |
| Other Non-Current Assets |
27,421,108.23 |
| Sub-Total of Non-Current Assets |
2,183,143,113.72 |
| Total Assets |
10,981,276,494.51 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
404,000,000.00 |
| Accounts Payable |
523,361,132.78 |
| Accounts Received In Advance |
3,805,347.34 |
| Employee Compensation Payable |
295,262,238.45 |
| Taxes Payable |
578,751,624.84 |
| Interest Payable |
-- |
| Dividend Payable |
1,821,491.94 |
| Other payables |
924,947,723.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,723,308.73 |
| Other Current Liabilities |
137,353,950.27 |
| Sub-Total of Current Liabilities |
3,675,120,328.37 |
| Long-term Loans |
80,054,617.37 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
26,546,748.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
186,159,251.18 |
| Total Liabilities |
3,861,279,579.55 |
| Paid-In Capital(Or Share Stock) |
333,195,979.00 |
| Capital Surplus |
823,601,532.57 |
| Surplus Reserve |
245,661,793.43 |
| LESS:Treasury Stock |
32,644,824.88 |
| Undistributed Profits |
5,527,837,144.19 |
| Minority Stockholder's Interest |
207,859,855.95 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,912,137,059.01 |
| Owner's Equity（Stockholder's Equity） |
7,119,996,914.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,981,276,494.51 |
